🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInsurance & Access2026 payer coverage update — GLP-1 formulary changes by insurer Page 11

2026 payer coverage update — GLP-1 formulary changes by insurer

InsuranceTom Mon, Feb 26, 2024 at 4:00 PM 377 replies 33,823 viewsPage 11 of 20
lori_vegas
Member
378
1,678
Aug 2024
Las Vegas, NV
Apr 25, 2024 at 6:18 AM#51
LipidDoc_ATL said:
If two explanations both fit, the useful question is which one predicts something the other does not.

This is my experience too, for whatever a second data point is worth.

Last edited: Apr 25, 2024 at 8:18 AM
15 13amy_econ_NJ, bbq_ray_KC, oliver_london and 12 others
Reply Quote Save Share Report
Dr.SurgeonPGH
Senior Member
1,345
6,789
Mar 2024
Pittsburgh, PA
Apr 26, 2024 at 11:31 PM#52
LipidDoc_ATL said:
If two explanations both fit, the useful question is which one predicts something the other does not.

Adding the part of the answer the thread has not reached. The version of this that has an answer is narrower than the version being asked. Narrow it and it becomes tractable; leave it broad and the thread will produce nine confident and incompatible replies.

Last edited: Apr 27, 2024 at 2:31 AM
16 14TomTeleRx, DoseLogDan, SleepFixSam and 13 others
Reply Quote Save Share Report
tom_AK
New Member
28
112
Jan 2026
Anchorage, AK
Apr 28, 2024 at 4:43 PM#53

Old thread, but it comes up first when you search for this, so it is worth updating. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

17 15tyler_CSCS, VanRx_Mike, steve_okc and 14 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
wei_SG
Member
234
890
Nov 2024
Singapore, SG
Apr 30, 2024 at 9:54 AM#54

A narrower follow-up, since the general answer is now clear:

Was that from a primary source or from a summary of one?

18 16RetaRick_CA, JenPlateau, SallyK_inj and 15 others
Reply Quote Save Share Report
LondonLisa
Member
912
3,456
Mar 2024
London, UK
May 2, 2024 at 3:04 AM#55
tom_AK said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

This is where I part company with the consensus forming above. Not convinced. The evidence being cited is consistent with the conclusion and also consistent with two other conclusions nobody has ruled out.

19 17SallyK_inj, CryptoCarl, MariaRD and 16 others
Reply Quote Save Share Report

Similar Threads

Prior authorization success: step-by-step guide with templates5 replies
Cigna now covering Zepbound — how I got approved13 replies
Appeal letter template — denied PA for GLP-1 medications4 replies
Mounjaro savings card — manufacturer program changes 202610 replies
Medicare Part D GLP-1 coverage — what's covered in 202610 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register